Clinical Trial Update: Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating adapted cognitive/affective remediation for cannabis misuse in individuals with schizophrenia or schizoaffective disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1, Phase 2 | Status: COMPLETED